The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
C5 Inhibitor Avacincaptad Pegol for Geographic Atrophy Due to Age-Related Macular Degeneration
Open accessAbstract
PURPOSE: The complement pathway may play a key role in the pathogenesis of age-related macular degeneration (AMD). The safety and efficacy of avacincaptad pegol (Zimura, IVERIC bio Inc, New York, NY), a C5 inhibitor, were assessed in participants with geographic atrophy (GA) secondary to AMD (GATHER1 Study). DESIGN: International, prospective, randomized, double-masked, sham-controlled, pivotal phase 2/3 clinical trial. PARTICIPANTS: A total of 286 participants with GA secondary to AMD. MAIN OUTCOME MEASURES: The primary efficacy endpoint was the mean rate of change in GA over 12 months measured by fundus autofluorescence (FAF) at 3 timepoints: baseline, month 6, and month 12. RESULTS: The reduction in the mean rate of GA growth (square root transformation) over 12 months was 27.4% (P = 0.0072) for the avacincaptad pegol 2 mg cohort and 27.8% (P = 0.0051) for the avacincaptad pegol 4 mg cohort compared with their corresponding sham cohorts. The results for both dose groups were statistically significant. Avacincaptad pegol was generally well tolerated after monthly administration over 12 months. There were no avacincaptad pegol-related adverse events (AEs) or inflammation. Further, there were no ocular serious AEs (SAEs) and no cases of endophthalmitis. The most frequent ocular AEs were related to the injection procedure. CONCLUSIONS: Intravitreal administration of avacincaptad pegol 2 mg and 4 mg led to a significant reduction of GA growth in eyes with AMD over a 12-month period. Because C5 inhibition theoretically preserves C3 activity, it may offer additional safety advantages. A second confirmatory pivotal clinical trial is underway to confirm the efficacy and safety of avacincaptad pegol in slowing the GA growth (GATHER2 Study).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ranibizumab for Neovascular Age-Related Macular Degeneration
Rosenfeld, P. J., Brown, D. M., Heier, J. S., Boyer, D. S., Kaiser, P. K., Chung, C. Y., & Kim, R. Y. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa054481 · Cited by 5,886
The NLRP3 inflammasome: molecular activation and regulation to therapeutics
Swanson, K. V., Deng, M., & Ting, J. P.-Y. (2019) · Nature Reviews Immunology · doi:10.1038/s41577-019-0165-0 · Cited by 4,884
Complement factor H polymorphism in age-related macular degeneration
Klein, R. J., Zeiss, C., Chew, E. Y., Tsai, J.-Y., Sackler, R. S., Haynes, C., Henning, A. K., SanGiovanni, J. P., Mane, S. M., Mayne, S. T., et al. (2005) · Science · doi:10.1126/science.1109557 · Cited by 4,492
Ranibizumab versus Verteporfin for Neovascular Age-Related Macular Degeneration
Brown, D. M., Kaiser, P. K., Michels, M., Soubrane, G., Heier, J. S., Kim, R. Y., Sy, J. P., & Schneider, S. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa062655 · Cited by 3,522
Prevalence of Age-Related Macular Degeneration in the United States
(2004) · Archives of Ophthalmology · doi:10.1001/archopht.122.4.564 · Cited by 2,736
Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration
Heier, J. S., Brown, D. M., Chong, V., Korobelnik, J.-F., Kaiser, P. K., Nguyen, Q. D., Kirchhof, B., Ho, A., Ogura, Y., Yancopoulos, G. D., et al. (2012) · Ophthalmology · doi:10.1016/j.ophtha.2012.09.006 · Cited by 2,485
Complement factor H polymorphism and age-related macular degeneration
Edwards, A. O., Ritter, R., Abel, K. J., Manning, A., Panhuysen, C., & Farrer, L. A. (2005) · Science · doi:10.1126/science.1110189 · Cited by 2,449
Complement factor H variant increases the risk of age-related macular degeneration
Haines, J. L., Hauser, M. A., Schmidt, S., Scott, W. K., Olson, L. M., Gallins, P., Spencer, K. L., Kwan, S. Y., Noureddine, M., Gilbert, J. R., et al. (2005) · Science · doi:10.1126/science.1110359 · Cited by 2,424
Hageman, G. S., Anderson, D. H., Johnson, L. V., Hancox, L. S., Taiber, A. J., Hardisty, L. I., Hageman, J. L., Stockman, H. A., Borchardt, J. D., Gehrs, K. M., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501536102 · Cited by 1,961
Ranibizumab and Bevacizumab for Treatment of Neovascular Age-related Macular Degeneration
Martin, D. F., Maguire, M. G., Fine, S. L., Ying, G.-S., Jaffe, G. J., Grunwald, J. E., Toth, C., Redford, M., & Ferris, F. L. (2012) · Ophthalmology · doi:10.1016/j.ophtha.2012.03.053 · Cited by 1,715
Self-citationAge-related macular degeneration
Mitchell, P., Liew, G., Gopinath, B., & Wong, T. Y. (2018) · The Lancet · doi:10.1016/s0140-6736(18)31550-2 · Cited by 1,511
A role for local inflammation in the formation of drusen in the aging eye
Anderson, D. H., Mullins, R. F., Hageman, G. S., & Johnson, L. V. (2002) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(02)01624-0 · Cited by 1,087
Liao, D. S., Grossi, F. V., El Mehdi, D., Gerber, M. R., Brown, D. M., Heier, J. S., Wykoff, C. C., Singerman, L. J., Abraham, P., Grassmann, F., et al. (2020) · Ophthalmology · doi:10.1016/j.ophtha.2019.07.011 · Cited by 519
Pennington, K. L., & DeAngelis, M. M. (2016) · Eye and Vision · doi:10.1186/s40662-016-0063-5 · Cited by 480
Complement and Its Receptors: New Insights into Human Disease
Holers, V. M. (2014) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032713-120154 · Cited by 430
Holz, F. G., Strauss, E. C., Schmitz-Valckenberg, S., & van Lookeren Campagne, M. (2014) · Ophthalmology · doi:10.1016/j.ophtha.2013.11.023 · Cited by 402
Holz, F. G., Sadda, S. R., Busbee, B., Chew, E. Y., Mitchell, P., Tufail, A., Brittain, C., Ferrara, D., Gray, S., Honigberg, L., et al. (2018) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2018.1544 · Cited by 354
Complement — tapping into new sites and effector systems
Kolev, M., Friec, G. L., & Kemper, C. (2014) · Nature Reviews Immunology · doi:10.1038/nri3761 · Cited by 349
Sunness, J. S., Rubin, G. S., Applegate, C. A., Bressler, N. M., Marsh, M. J., Hawkins, B. S., & Haselwood, D. (1997) · Ophthalmology · doi:10.1016/s0161-6420(97)30079-7 · Cited by 309
Yehoshua, Z., Rosenfeld, P. J., Gregori, G., Feuer, W. J., Falcão, M., Lujan, B. J., & Puliafito, C. (2011) · Ophthalmology · doi:10.1016/j.ophtha.2010.08.018 · Cited by 292
Coulthard, L. G., & Woodruff, T. M. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1403068 · Cited by 285
Change in Area of Geographic Atrophy in the Age-Related Eye Disease Study: AREDS Report Number 26
(2009) · Archives of Ophthalmology · doi:10.1001/archophthalmol.2009.198 · Cited by 276
Boyer, D. S., Schmidt-Erfurth, U., van Lookeren Campagne, M., Henry, E. C., & Brittain, C. (2017) · Retina · doi:10.1097/iae.0000000000001392 · Cited by 258
Jaffe, G. J., Ying, G.-S., Toth, C. A., Daniel, E., Grunwald, J. E., Martin, D. F., & Maguire, M. G. (2019) · Ophthalmology · doi:10.1016/j.ophtha.2018.08.035 · Cited by 248
Self-citationCsaky, K., Ferris, F., Chew, E. Y., Nair, P., Cheetham, J. K., & Duncan, J. L. (2017) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.17-22339 · Cited by 231
Self-citationThe prevalence of age-related maculopathy: the visual impairment project
VanNewkirk, M. (2000) · Ophthalmology · doi:10.1016/s0161-6420(00)00175-5 · Cited by 222
Grunwald, J. E., Pistilli, M., Daniel, E., Ying, G.-S., Pan, W., Jaffe, G. J., Toth, C. A., Hagstrom, S. A., Maguire, M. G., & Martin, D. F. (2017) · Ophthalmology · doi:10.1016/j.ophtha.2016.09.012 · Cited by 214
Self-citationBhisitkul, R. B., Mendes, T. S., Rofagha, S., Enanoria, W., Boyer, D. S., Sadda, S. R., & Zhang, K. (2015) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2015.01.032 · Cited by 210
The prevalence of age-related maculopathy: The visual impairment project
Mukesh, B., VanNewkirk, Wang, J., Mitchell, P. B., Taylor, H. R., & McCarty, C. A. (2000) · Investigative Ophthalmology & Visual Science · Cited by 200
Feuer, W. J., Yehoshua, Z., Gregori, G., Penha, F. M., Chew, E. Y., Ferris, F. L., Clemons, T. E., Lindblad, A. S., & Rosenfeld, P. J. (2013) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2013.572 · Cited by 183
Rudnicka, A. R., Kapetanakis, V. V., Jarrar, Z., Wathern, A. K., Wormald, R., Fletcher, A. E., Cook, D. G., & Owen, C. G. (2015) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2015.04.003 · Cited by 181
Wu, M. C. L., Brennan, F. H., Lynch, J. P. L., Mantovani, S., Phipps, S., Wetsel, R. A., Ruitenberg, M. J., Taylor, S. M., & Woodruff, T. M. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1218815110 · Cited by 165
Arbore, G., & Kemper, C. (2016) · European Journal of Immunology · doi:10.1002/eji.201546131 · Cited by 150
Evidence for an inflammatory process in age-related macular degeneration gains new support
Bok, D. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502819102 · Cited by 129
C3- and CR3-dependent microglial clearance protects photoreceptors in retinitis pigmentosa
Silverman, S. M., Ma, W., Wang, X., Zhao, L., & Wong, W. T. (2019) · The Journal of Experimental Medicine · doi:10.1084/jem.20190009 · Cited by 123
Chakravarthy, U., Bailey, C., Johnston, R. L., McKibbin, M., Khan, R. S., Mahmood, S., Downey, L., Dhingra, N., Brand, C., Brittain, C. J., et al. (2018) · Ophthalmology · doi:10.1016/j.ophtha.2017.11.036 · Cited by 122
Brandstetter, C., Holz, F. G., & Krohne, T. U. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.671180 · Cited by 72
Hollmann, T. J., Mueller‐Ortiz, S. L., Braun, M., et al. (2007) · Molecular Immunology · doi:10.1016/j.molimm.2007.10.037 · Cited by 67
Abdelfattah, N. S., Zhang, H., Boyer, D. S., & Sadda, S. R. (2016) · Retina · doi:10.1097/iae.0000000000001059 · Cited by 63
Some Design Issues in Trials of Microbicides for the Prevention of HIV Infection
Fleming, T. R., & Richardson, B. A. (2004) · The Journal of Infectious Diseases · doi:10.1086/422603 · Cited by 62
C5a, But Not C3a, Increases VEGF Secretion in ARPE-19 Human Retinal Pigment Epithelial Cells
Cortright, D. N., Meade, R., Waters, S. M., Chenard, B. L., & Krause, J. E. (2009) · Current Eye Research · doi:10.1080/02713680802546658 · Cited by 52
Complement Factor H Polymorphism in Age-Related Macular Degeneration
Narayanan, R., Butani, V., Boyer, D. S., Atilano, S. R., Resende, G. P., Kim, D. S., Chakrabarti, S., Kuppermann, B. D., Khatibi, N. H., Chwa, M., et al. (2007) · Ophthalmology · doi:10.1016/j.ophtha.2006.10.035 · Cited by 50
Retinal pigment epithelial cells mitigate the effects of complement attack by endocytosis of C5b-9
Georgiannakis, A., Burgoyne, T., Lueck, K., Futter, C., Greenwood, J., & Moss, S. E. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1500937 · Cited by 41
Living with Geographic Atrophy: An Ethnographic Study
Sivaprasad, S., Tschosik, E., Guymer, R. H., Kapre, A., Suñer, I. J., Joussen, A. M., Lanzetta, P., & Ferrara, D. (2019) · Ophthalmology and Therapy · doi:10.1007/s40123-019-0160-3 · Cited by 38
Miller, M. E., Morgan, T. M., Espeland, M. A., & Emerson, S. S. (2001) · Statistics in Medicine · doi:10.1002/sim.904 · Cited by 20
C3 Function and Inhibition in Geographic Atrophy: Interesting Insights from a Phase 2 Study
Wong, W. T. (2020) · Ophthalmology · doi:10.1016/j.ophtha.2019.09.008 · Cited by 6
Cited by
Age-related macular degeneration
Fleckenstein, M., Keenan, T. D. L., Guymer, R. H., Chakravarthy, U., Schmitz-Valckenberg, S., Klaver, C. C., Wong, W. T., & Chew, E. Y. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-021-00265-2 · Cited by 978
Age-related macular degeneration
Guymer, R. H., & Campbell, T. G. (2023) · The Lancet · doi:10.1016/s0140-6736(22)02609-5 · Cited by 502
Khanani, A. M., Patel, S. S., Staurenghi, G., Tadayoni, R., Danzig, C. J., Eichenbaum, D. A., Hsu, J., Wykoff, C. C., Heier, J. S., Lally, D. R., et al. (2023) · The Lancet · doi:10.1016/s0140-6736(23)01583-0 · Cited by 366
Self-citationThe complement system in age-related macular degeneration
Armento, A., Ueffing, M., & Clark, S. J. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-021-03796-9 · Cited by 258
Patel, S. S., Lally, D. R., Hsu, J., Wykoff, C. C., Eichenbaum, D., Heier, J. S., Jaffe, G. J., Westby, K., Desai, D., Zhu, L., et al. (2023) · Eye · doi:10.1038/s41433-023-02497-w · Cited by 147
Self-citation
Metadata
- Authors
- Jaffe, G. J., Westby, K., Csaky, K. G., Monés, J., Pearlman, J. A., Patel, S. S., Joondeph, B. C., Randolph, J., Masonson, H., & Rezaei, K. A.
- Venue
- Ophthalmology
- Publisher
- Elsevier BV
- Published
- 2021-04
- Volume
- 128
- Issue
- 4
- Pages
- 576-586
- ISSN
- 0161-6420 (ISSN-L)
- OpenAlex
- W3081661825
- Cited by
- 469
- References
- 46
- FWCI
- 37.79
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.